Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Yeoman

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Frontline Gastroenterology|March 17, 2022
Provision and standards of care for treatment and follow-up of patients with Autoimmune Hepatitis (AIH)Victoria Mary Gordon, Ratul Adhikary, Guruprasad P Aithal, et al.
Hepatology (Baltimore, Md.)|March 20, 2024
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?David E J Jones, Ulrich Beuers, Alan Bonder, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 14, 2022
Treatment and Outcome of Autoimmune Hepatitis (AIH): Audit of 28 UK centresVictoria Gordon, Ratul Adhikary, Victoria Appleby, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 19, 2018
Diagnosis, presentation and initial severity of Autoimmune Hepatitis (AIH) in patients attending 28 hospitals in the UKVictoria Gordon, Ratul Adhikary, Victoria Appleby, et al.
Lancet (London, England)|December 20, 2016
New metrics for the Lancet Standing Commission on Liver Disease in the UKRoger Williams, Graeme Alexander, Richard Aspinall, et al.
Lancet (London, England)|March 14, 2021
New dimensions for hospital services and early detection of disease: a Review from the Lancet Commission into liver disease in the UKRoger Williams, Charles Alessi, Graeme Alexander, et al.
Lancet (London, England)|December 5, 2017
Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UKRoger Williams, Graeme Alexander, Iain Armstrong, et al.
Hepatology Communications|May 2, 2024
Pragmatic strategies to address health disparities along the continuum of care in chronic liver diseaseMayur Brahmania, Shari Rogal, Marina Serper, et al.
The Lancet. Gastroenterology & Hepatology|May 1, 2022
Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest GroupStuart McPherson, Matthew J Armstrong, Jeremy F Cobbold, et al.
Lancet (London, England)|December 4, 2019
Unacceptable failures: the final report of the Lancet Commission into liver disease in the UKRoger Williams, Guruprasad Aithal, Graeme J Alexander, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Frontline Gastroenterology|March 17, 2022
Provision and standards of care for treatment and follow-up of patients with Autoimmune Hepatitis (AIH)Victoria Mary Gordon, Ratul Adhikary, Guruprasad P Aithal, et al.
Hepatology (Baltimore, Md.)|March 20, 2024
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?David E J Jones, Ulrich Beuers, Alan Bonder, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 14, 2022
Treatment and Outcome of Autoimmune Hepatitis (AIH): Audit of 28 UK centresVictoria Gordon, Ratul Adhikary, Victoria Appleby, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 19, 2018
Diagnosis, presentation and initial severity of Autoimmune Hepatitis (AIH) in patients attending 28 hospitals in the UKVictoria Gordon, Ratul Adhikary, Victoria Appleby, et al.
Lancet (London, England)|December 20, 2016
New metrics for the Lancet Standing Commission on Liver Disease in the UKRoger Williams, Graeme Alexander, Richard Aspinall, et al.
Lancet (London, England)|March 14, 2021
New dimensions for hospital services and early detection of disease: a Review from the Lancet Commission into liver disease in the UKRoger Williams, Charles Alessi, Graeme Alexander, et al.
Lancet (London, England)|December 5, 2017
Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UKRoger Williams, Graeme Alexander, Iain Armstrong, et al.
Hepatology Communications|May 2, 2024
Pragmatic strategies to address health disparities along the continuum of care in chronic liver diseaseMayur Brahmania, Shari Rogal, Marina Serper, et al.
The Lancet. Gastroenterology & Hepatology|May 1, 2022
Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest GroupStuart McPherson, Matthew J Armstrong, Jeremy F Cobbold, et al.
Lancet (London, England)|December 4, 2019
Unacceptable failures: the final report of the Lancet Commission into liver disease in the UKRoger Williams, Guruprasad Aithal, Graeme J Alexander, et al.
Pageof 4